You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 143 No. 12, December 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Invited Critique
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Colon Cancer
 •Oncology, Other
 •Surgery
 •Surgical Interventions
 •Surgical Oncology
 •Prognosis/ Outcomes
 •Hepatobiliary Surgery
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Perioperative Carcinoembryonic Antigen Measurements to Predict Curability After Liver Resection for Colorectal Metastases—Invited Critique

Anton J. Bilchik, MD, PhD

Arch Surg. 2008;143(12):1158-1159.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hepatic resection is the only curative option for patients with hepatic metastases from colorectal cancer (CRC). Five-year survival rates after resection have reached almost 60% in recent series.1-3 This is largely attributed to more sophisticated preoperative imaging techniques, highly sensitive intraoperative ultrasonographic detection of small metastases, improved surgical techniques, and more effective systemic therapies.3-4

Improved survival and decreased mortality for patients with hepatic CRC have changed the criteria for resection. In the past, surgical candidates were those with no more than 3 tumors, tumors less than 5 cm in greatest diameter, no bilobar disease, no extrahepatic disease, and tumors that could be removed with at least a 1-cm margin of normal hepatic parenchyma. In the modern era of hepatic surgery, the number of candidates for resection has been raised by innovative techniques to increase residual hepatic reserve (portal vein embolization, 2-stage hepatectomy, and radiofrequency ablation) . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Perioperative Carcinoembryonic Antigen Measurements to Predict Curability After Liver Resection for Colorectal Metastases: A Prospective Study
Elie Oussoultzoglou, Edoardo Rosso, Pascal Fuchshuber, Victor Stefanescu, Bala Diop, Giorgio Giraudo, Patrick Pessaux, Philippe Bachellier, and Daniel Jaeck
Arch Surg. 2008;143(12):1150-1158.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.